Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 758

1.

[Patient-Reported Outcome(PRO)to Measure Health-Related QOL in Lung Cancer Patients].

Sone S, Hase K, Takezaki A, Kakiuchi S, Konaka K.

Gan To Kagaku Ryoho. 2019 Jun;46(6):974-980. Review. Japanese.

PMID:
31273159
2.

Multicenter, Open-Label, Randomized Controlled Trial of Warfarin and Edoxaban Tosilate Hydrate for the Treatment of Deep Vein Thrombosis in Persons with Severe Motor Intellectual Disabilities.

Ohmori H, Nakamura M, Kada A, Saito AM, Sanayama Y, Shinagawa T, Fujita H, Wakisaka A, Maruhashi K, Okumura A, Takizawa N, Murata H, Inoue M, Kaneko H, Taniguchi H, Kawasaki M, Sano N, Akaboshi S, Tanuma N, Sone S, Kumode M, Takechi T, Koretsune Y, Sumimoto R, Miyanomae T.

Kurume Med J. 2018 Dec 21;65(1):11-16. doi: 10.2739/kurumemedj.MS651003. Epub 2018 Aug 30.

3.

Assessment of the timing and degree of smolt development in southern populations of masu salmon Oncorhynchus masou.

Inatani Y, Ineno T, Sone S, Matsumoto N, Uchida K, Shimizu M.

J Fish Biol. 2018 Sep;93(3):490-500. doi: 10.1111/jfb.13647.

4.

Thymidine catabolism promotes NADPH oxidase-derived reactive oxygen species (ROS) signalling in KB and yumoto cells.

Tabata S, Yamamoto M, Goto H, Hirayama A, Ohishi M, Kuramoto T, Mitsuhashi A, Ikeda R, Haraguchi M, Kawahara K, Shinsato Y, Minami K, Saijo A, Toyoda Y, Hanibuchi M, Nishioka Y, Sone S, Esumi H, Tomita M, Soga T, Furukawa T, Akiyama SI.

Sci Rep. 2018 Apr 30;8(1):6760. doi: 10.1038/s41598-018-25189-y.

5.

Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer.

Goto H, Okano Y, Machida H, Hatakeyama N, Ogushi F, Haku T, Kanematsu T, Urata T, Kakiuchi S, Hanibuchi M, Sone S, Nishioka Y.

Respir Investig. 2018 Jan;56(1):80-86. doi: 10.1016/j.resinv.2017.09.003. Epub 2017 Oct 21.

PMID:
29325686
6.

Disappearance of perihepatic lymph node enlargement after hepatitis C viral eradication with direct-acting antivirals.

Hikita H, Sato M, Endo M, Sato M, Soroida Y, Kobayashi T, Gotoh H, Iwai T, Nakagomi R, Tateishi R, Komuro T, Sone S, Koike K, Yatomi Y, Ikeda H.

J Viral Hepat. 2018 Apr;25(4):329-334. doi: 10.1111/jvh.12819. Epub 2017 Dec 8.

PMID:
29091333
7.

Ultrasound evaluation of liver stiffness: accuracy of ultrasound imaging for the prediction of liver cirrhosis as evaluated using a liver stiffness measurement.

Endo M, Soroida Y, Sato M, Kobayashi T, Hikita H, Sato M, Gotoh H, Iwai T, Sone S, Sasano T, Sumi Y, Koike K, Yatomi Y, Ikeda H.

J Med Dent Sci. 2017;64(2-3):27-34. doi: 10.11480/jmds.640301.

8.

Evaluation of human nonmercaptalbumin as a marker for oxidative stress and its association with various parameters in blood.

Masudo R, Yasukawa K, Nojiri T, Yoshikawa N, Shimosaka H, Sone S, Oike Y, Ugawa A, Yamazaki T, Shimokado K, Yatomi Y, Ikeda H.

J Clin Biochem Nutr. 2017 Sep;61(2):79-84. doi: 10.3164/jcbn.17-5. Epub 2017 Jul 20.

9.

Thymidine Catabolism as a Metabolic Strategy for Cancer Survival.

Tabata S, Yamamoto M, Goto H, Hirayama A, Ohishi M, Kuramoto T, Mitsuhashi A, Ikeda R, Haraguchi M, Kawahara K, Shinsato Y, Minami K, Saijo A, Hanibuchi M, Nishioka Y, Sone S, Esumi H, Tomita M, Soga T, Furukawa T, Akiyama SI.

Cell Rep. 2017 May 16;19(7):1313-1321. doi: 10.1016/j.celrep.2017.04.061.

10.

Anti-epileptics alter hypothyroidism of patients with severe motor and intellectual disabilities.

Hirayama T, Saijo H, Kohji T, Ezoe T, Sone S, Araki K, Hamaguchi H, Suzuki H, KKurata K.

No To Hattatsu. 2017 Jan;49(1):19-24. Japanese.

PMID:
30011149
11.

A method for evaluating the performance of computer-aided detection of pulmonary nodules in lung cancer CT screening: detection limit for nodule size and density.

Kobayashi H, Ohkubo M, Narita A, Marasinghe JC, Murao K, Matsumoto T, Sone S, Wada S.

Br J Radiol. 2017 Feb;90(1070):20160313. doi: 10.1259/bjr.20160313. Epub 2017 Jan 3.

12.

Ulcers on the epiglottis caused by a nasogastric tube in three adults with severe motor and intellectual disabilities.

Sone S, Yoshino A, Kawahara Y, Takeda Y, Hamaguchi H, Ezoe T, Saijo H, Araki K, Kurata K.

No To Hattatsu. 2016 Nov;48(6):434-8. Japanese.

PMID:
30010296
13.
14.

[Ethical Guidelines for Clinical Trials in Medical Research Involving Human Subjects].

Sone S.

Gan To Kagaku Ryoho. 2015 Aug;42(8):893-902. Review. Japanese.

PMID:
26321701
15.

Effects of inflow velocity profile on two-dimensional hemodynamic analysis by ordinary and ultrasonic-measurement-integrated simulations.

Kato T, Sone S, Funamoto K, Hayase T, Kadowaki H, Taniguchi N.

Med Biol Eng Comput. 2016 Sep;54(9):1331-9. doi: 10.1007/s11517-015-1376-6. Epub 2015 Aug 26.

PMID:
26307203
16.

Ablation of the p16(INK4a) tumour suppressor reverses ageing phenotypes of klotho mice.

Sato S, Kawamata Y, Takahashi A, Imai Y, Hanyu A, Okuma A, Takasugi M, Yamakoshi K, Sorimachi H, Kanda H, Ishikawa Y, Sone S, Nishioka Y, Ohtani N, Hara E.

Nat Commun. 2015 Apr 29;6:7035. doi: 10.1038/ncomms8035.

17.

[Management of massive transfusion - the role of the blood transfusion service].

Sone S, Tsuno H, Okazaki H.

Rinsho Byori. 2014 Dec;62(12):1280-5. Review. Japanese.

PMID:
25823247
18.

Effects of universal vs bedside leukoreductions on the alloimmunization to platelets and the platelet transfusion refractoriness.

Mishima Y, Tsuno NH, Matsuhashi M, Yoshizato T, Sato T, Ikeda T, Watanabe-Okochi N, Nagura Y, Sone S, Kurokawa M, Okazaki H.

Transfus Apher Sci. 2015 Feb;52(1):112-21. doi: 10.1016/j.transci.2014.11.001. Epub 2014 Nov 11.

PMID:
25467707
19.

Early growth response 4 is involved in cell proliferation of small cell lung cancer through transcriptional activation of its downstream genes.

Matsuo T, Dat le T, Komatsu M, Yoshimaru T, Daizumoto K, Sone S, Nishioka Y, Katagiri T.

PLoS One. 2014 Nov 20;9(11):e113606. doi: 10.1371/journal.pone.0113606. eCollection 2014.

20.

Visualization of human inner ear anatomy with high-resolution MR imaging at 7T.

Naganawa S, Sone SM.

AJNR Am J Neuroradiol. 2014 Dec;35(12):E10. doi: 10.3174/ajnr.A4161. Epub 2014 Oct 16. No abstract available.

21.

Development and feasibility study of a two-dimensional ultrasonic-measurement-integrated blood flow analysis system for hemodynamics in carotid arteries.

Kato T, Funamoto K, Hayase T, Sone S, Kadowaki H, Shimazaki T, Jibiki T, Miyama K, Liu L.

Med Biol Eng Comput. 2014 Nov;52(11):933-943. doi: 10.1007/s11517-014-1193-3. Epub 2014 Sep 6.

PMID:
25192923
22.

Safety and efficacy of preoperative autologous blood donation for high-risk pregnant women: experience of a large university hospital in Japan.

Yamamoto Y, Yamashita T, Tsuno NH, Nagamatsu T, Okochi N, Hyodo H, Ikeda T, Kawabata M, Kamei Y, Nagura Y, Sone S, Fujii T, Takahashi K, Kozuma S.

J Obstet Gynaecol Res. 2014 May;40(5):1308-16. doi: 10.1111/jog.12348. Epub 2014 Apr 21.

PMID:
24750371
24.

Thymidine phosphorylase regulates the expression of CXCL10 in rheumatoid arthritis fibroblast-like synoviocytes.

Toyoda Y, Tabata S, Kishi J, Kuramoto T, Mitsuhashi A, Saijo A, Kawano H, Goto H, Aono Y, Hanibuchi M, Horikawa H, Nakajima T, Furukawa T, Sone S, Akiyama S, Nishioka Y.

Arthritis Rheumatol. 2014 Mar;66(3):560-8. doi: 10.1002/art.38263.

25.

Targeted reduction of CCR4⁺ cells is sufficient to suppress allergic airway inflammation.

Honjo A, Ogawa H, Azuma M, Tezuka T, Sone S, Biragyn A, Nishioka Y.

Respir Investig. 2013 Dec;51(4):241-9. doi: 10.1016/j.resinv.2013.04.007. Epub 2013 Jun 22.

26.

The role of alloantibodies against human platelet antigen-15 in multiply platelet transfused patients.

Matsuhashi M, Tsuno NH, Sone S, Mishima Y, Nagura Y, Watanabe-Okochi N, Ikeda T, Kashiwase K, Fukuda S, Iriyama T, Hyodo H, Yamashita T, Kamei Y, Arai S, Minami M, Fujii T, Kurokawa M, Tozuka M, Takahashi K, Santoso S.

Transfusion. 2014 Apr;54(4):1093-9. doi: 10.1111/trf.12455. Epub 2013 Oct 22.

PMID:
24147542
27.

Simultaneous analysis system for blood pressure and flow using photoplethysmography and ultrasonic-measurement-integrated simulation.

Sone S, Hayase T, Funamoto K, Shirai A.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:1827-30. doi: 10.1109/EMBC.2013.6609878.

PMID:
24110065
28.

[Child neurologists for the next generation. Interviewed by Ohno, Oka and Sone].

Ohno K, Oka A, Sone S.

No To Hattatsu. 2013 May;45(3):183-92. Japanese. No abstract available.

PMID:
23785831
29.

A novel targeting therapy of malignant mesothelioma using anti-podoplanin antibody.

Abe S, Morita Y, Kaneko MK, Hanibuchi M, Tsujimoto Y, Goto H, Kakiuchi S, Aono Y, Huang J, Sato S, Kishuku M, Taniguchi Y, Azuma M, Kawazoe K, Sekido Y, Yano S, Akiyama S, Sone S, Minakuchi K, Kato Y, Nishioka Y.

J Immunol. 2013 Jun 15;190(12):6239-49. doi: 10.4049/jimmunol.1300448. Epub 2013 May 20.

30.

Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice.

Kinoshita K, Aono Y, Azuma M, Kishi J, Takezaki A, Kishi M, Makino H, Okazaki H, Uehara H, Izumi K, Sone S, Nishioka Y.

Am J Respir Cell Mol Biol. 2013 Oct;49(4):536-43. doi: 10.1165/rcmb.2012-0277OC.

PMID:
23642017
31.

Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice.

Makino H, Aono Y, Azuma M, Kishi M, Yokota Y, Kinoshita K, Takezaki A, Kishi J, Kawano H, Ogawa H, Uehara H, Izumi K, Sone S, Nishioka Y.

J Med Invest. 2013;60(1-2):127-37.

32.

Surfactant protein A suppresses lung cancer progression by regulating the polarization of tumor-associated macrophages.

Mitsuhashi A, Goto H, Kuramoto T, Tabata S, Yukishige S, Abe S, Hanibuchi M, Kakiuchi S, Saijo A, Aono Y, Uehara H, Yano S, Ledford JG, Sone S, Nishioka Y.

Am J Pathol. 2013 May;182(5):1843-53. doi: 10.1016/j.ajpath.2013.01.030. Epub 2013 Mar 14.

33.

The current status of autologous blood transfusion in Japan--the importance of pre-deposit autologous blood donation program and the needs to achieve patient blood management.

Tsuno NH, Nagura Y, Kawabata M, Matsuhashi M, Sone S, Ikeda T, Okochi N, Takahashi K.

Transfus Apher Sci. 2013 Dec;49(3):673-80. doi: 10.1016/j.transci.2013.02.002. Epub 2013 Mar 13.

PMID:
23491867
34.

[Introduction of preventive measures toward contact infection without affecting the efficiency of the outpatient blood collection].

Sone S, Yokota H, Takahashi K, Yatomi Y.

Rinsho Byori. 2012 Sep;60(9):853-9. Japanese.

PMID:
23157114
35.

Serum proteome analysis in patients with rheumatoid arthritis receiving therapy with etanercept, a chimeric tumor necrosis factor-alpha receptor.

Yanagida M, Jung G, Tanaka Y, Sone S, Fujishiro M, Ikeda K, Nozawa K, Kaneko H, Takasaki Y, Ogawa H, Takamori K, Sekigawa I.

Int J Rheum Dis. 2012 Oct;15(5):486-95. doi: 10.1111/j.1756-185X.2012.01816.x. Epub 2012 Sep 25.

PMID:
23083039
36.

Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations.

Yamada T, Takeuchi S, Fujita N, Nakamura A, Wang W, Li Q, Oda M, Mitsudomi T, Yatabe Y, Sekido Y, Yoshida J, Higashiyama M, Noguchi M, Uehara H, Nishioka Y, Sone S, Yano S.

Oncogene. 2013 Sep 12;32(37):4427-35. doi: 10.1038/onc.2012.446. Epub 2012 Oct 8.

PMID:
23045273
37.

Macrophage stimulating protein promotes liver metastases of small cell lung cancer cells by affecting the organ microenvironment.

Sato S, Hanibuchi M, Kuramoto T, Yamamori N, Goto H, Ogawa H, Mitsuhashi A, Van TT, Kakiuchi S, Akiyama S, Nishioka Y, Sone S.

Clin Exp Metastasis. 2013 Mar;30(3):333-44. doi: 10.1007/s10585-012-9540-y. Epub 2012 Sep 26.

PMID:
23011677
38.

Dll4-Fc, an inhibitor of Dll4-notch signaling, suppresses liver metastasis of small cell lung cancer cells through the downregulation of the NF-κB activity.

Kuramoto T, Goto H, Mitsuhashi A, Tabata S, Ogawa H, Uehara H, Saijo A, Kakiuchi S, Maekawa Y, Yasutomo K, Hanibuchi M, Akiyama S, Sone S, Nishioka Y.

Mol Cancer Ther. 2012 Dec;11(12):2578-87. doi: 10.1158/1535-7163.MCT-12-0640. Epub 2012 Sep 18.

39.

Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.

Takeuchi S, Wang W, Li Q, Yamada T, Kita K, Donev IS, Nakamura T, Matsumoto K, Shimizu E, Nishioka Y, Sone S, Nakagawa T, Uenaka T, Yano S.

Am J Pathol. 2012 Sep;181(3):1034-43. doi: 10.1016/j.ajpath.2012.05.023. Epub 2012 Jul 9.

PMID:
22789825
40.

Thymidine phosphorylase enhances reactive oxygen species generation and interleukin-8 expression in human cancer cells.

Tabata S, Ikeda R, Yamamoto M, Furukawa T, Kuramoto T, Takeda Y, Yamada K, Haraguchi M, Nishioka Y, Sone S, Akiyama S.

Oncol Rep. 2012 Sep;28(3):895-902. doi: 10.3892/or.2012.1887. Epub 2012 Jun 26.

PMID:
22751949
41.

SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model.

Van TT, Hanibuchi M, Goto H, Kuramoto T, Yukishige S, Kakiuchi S, Sato S, Sakaguchi S, Dat le T, Nishioka Y, Akiyama S, Sone S.

Respirology. 2012 Aug;17(6):984-90. doi: 10.1111/j.1440-1843.2012.02193.x.

PMID:
22574723
42.

Epidermal growth factor receptor-tyrosine kinase inhibitor (gefitinib) augments pneumonitis, but attenuates lung fibrosis in response to radiation injury in rats.

Miyake K, Tani K, Kakiuchi S, Suzuka C, Toyoda Y, Kishi J, Tezuka T, Yuasa S, Hanibuchi M, Aono Y, Nishioka Y, Sone S.

J Med Invest. 2012;59(1-2):174-85.

43.

Combined effects of prevention and quarantine on a breakout in SIR model.

Kato F, Tainaka K, Sone S, Morita S, Iida H, Yoshimura J.

Sci Rep. 2011;1:10. doi: 10.1038/srep00010. Epub 2011 Jun 14.

44.

Met kinase inhibitor E7050 reverses three different mechanisms of hepatocyte growth factor-induced tyrosine kinase inhibitor resistance in EGFR mutant lung cancer.

Wang W, Li Q, Takeuchi S, Yamada T, Koizumi H, Nakamura T, Matsumoto K, Mukaida N, Nishioka Y, Sone S, Nakagawa T, Uenaka T, Yano S.

Clin Cancer Res. 2012 Mar 15;18(6):1663-71. doi: 10.1158/1078-0432.CCR-11-1171. Epub 2012 Feb 8.

45.

Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice.

Dat le T, Matsuo T, Yoshimaru T, Kakiuchi S, Goto H, Hanibuchi M, Kuramoto T, Nishioka Y, Sone S, Katagiri T.

Int J Oncol. 2012 May;40(5):1455-69. doi: 10.3892/ijo.2012.1348. Epub 2012 Jan 27.

PMID:
22294041
46.

Psychiatric symptoms in a patient with Churg-Strauss syndrome.

Tezuka T, Azuma M, Goto H, Nishioka Y, Sone S.

Intern Med. 2012;51(3):301-3. Epub 2012 Feb 1.

47.

[Significance of COI disclosure in medical research in Japan].

Sone S.

Rinsho Shinkeigaku. 2011 Nov;51(11):868-71. Japanese.

PMID:
22277397
48.

Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.

Aono Y, Ledford JG, Mukherjee S, Ogawa H, Nishioka Y, Sone S, Beers MF, Noble PW, Wright JR.

Am J Respir Crit Care Med. 2012 Mar 1;185(5):525-36. doi: 10.1164/rccm.201103-0561OC. Epub 2011 Dec 28.

49.

Erlotinib prevents experimental metastases of human small cell lung cancer cells with no epidermal growth factor receptor expression.

Gabr AG, Goto H, Hanibuchi M, Ogawa H, Kuramoto T, Suzuki M, Saijo A, Kakiuchi S, Trung VT, Sakaguchi S, Moriya Y, Sone S, Nishioka Y.

Clin Exp Metastasis. 2012 Mar;29(3):207-16. doi: 10.1007/s10585-011-9443-3. Epub 2011 Dec 15.

PMID:
22170031
50.

Nerve growth factor derived from bronchial epithelium after chronic mite antigen exposure contributes to airway hyperresponsiveness by inducing hyperinnervation, and is inhibited by in vivo siRNA.

Ogawa H, Azuma M, Uehara H, Takahashi T, Nishioka Y, Sone S, Izumi K.

Clin Exp Allergy. 2012 Mar;42(3):460-70. doi: 10.1111/j.1365-2222.2011.03918.x. Epub 2011 Dec 14.

PMID:
22168511

Supplemental Content

Support Center